Events
20.04.2017

Cromos™ Pharma at the Swiss Biotech Day in Basel on 4 May 2017

Meet Cromos™ Pharma’s VP, International Business & Operations, Dr. Gearóid Tuohy in Basel at the Swiss Biotech Day on 4 May and find out how Cromos™ Pharma can assist you in your clinical drug development programmes.

The Swiss Biotech Day is the leading biotechnology conference in Switzerland. This event will bring together more than 500 senior executives from the life science industry across Europe. Programme highlights in 2017 will include key notes from renowned industry experts, the presentation of the Swiss biotech report, and the annual general assembly of the Swiss Biotech Association.

If you plan to attend the conference or to be in Basel on this date, then feel free to set up a face to face meeting with Dr. Tuohy directly.

Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include clinical monitoring, regulatory approvals, medical writing, feasibility assessments, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company.

Other Events:
news

Connect with Cromos Pharma at MAGI's Clinical Research vConference

Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).

17.09.2020
news

Join us at Bio in Philadelphia on June 3-6, 2019

16.05.2019
news

Meet us at Asco Annual Meeting 2019 In Chicago, USA on May 31 – June 4, 2019

13.05.2019
news

Meet us at the 11th Dia China Annual Meeting 2019 in Beijing, China on 20-23 May, 2019

30.04.2019
news

Join Cromos™ Pharma at the 12th European Biosimilars Congress in Berlin, Germany on 15-16 April, 2019

26.03.2019
news

2019 J.P. Morgan 37th Annual Healthcare Conference

10.12.2018
news

The XX Hungarian Clinical Pharmacology Congress

03.12.2018